Form 4: Galecto Interim CFO Reports Routine RSU Vesting and Tax-Related Stock Sale

Galecto, Inc.'s Interim CFO, Lori Firmani, reported the vesting of 374 restricted stock units and a subsequent sale of 147 shares to cover tax obligations on July 3, 2025.

Summary

• Lori Firmani, Interim CFO of Galecto, Inc. (GLTO), reported transactions involving the company's common stock and restricted stock units (RSUs) on July 3, 2025.
• A total of 374 restricted stock units (RSUs) vested and were converted into 374 shares of common stock.
• Concurrently, 147 shares of common stock were sold at a price of $3.39 per share to satisfy tax withholding obligations related to the RSU vesting.
• This sale was explicitly stated as mandated by the Issuer's election under its 2020 Equity Incentive Plan and did not represent a discretionary trade by the Reporting Person.
• Following these transactions, Lori Firmani beneficially owns 692 shares of common stock and 1,100 restricted stock units.
• The RSU award was originally granted on January 3, 2024, with one-third vesting on January 3, 2025, and one-sixth scheduled to vest ratably every six months thereafter, contingent on continued employment.

Sentiment

Score: 5

Explanation: The document is a factual report of an insider transaction (RSU vesting and tax-related sale), which is a routine and expected event. It contains no positive or negative strategic news, hence a neutral sentiment.

Positives

• The vesting of Restricted Stock Units indicates continued employment and compensation for the Interim CFO, aligning her interests with the company's performance.
• The sale of shares was non-discretionary and solely for tax obligations, which is a standard and expected practice for equity compensation vesting.

Negatives

• A portion of the vested shares was sold, resulting in a reduction of the Interim CFO's direct common stock holdings, although this was for tax purposes.

Future Outlook

The document indicates that one-sixth of the remaining Restricted Stock Units will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date.

Management Comments

• "Shares sold to cover tax obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its 2020 Equity Incentive Plan and does not represent a discretionary trade by the Reporting Person."

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically the vesting of equity compensation and a subsequent non-discretionary sale to cover tax liabilities. Such transactions are common across all industries, particularly in publicly traded companies where executive compensation often includes equity awards.

Comparison to Industry Standards

• The practice of granting Restricted Stock Units (RSUs) as part of executive compensation is a standard practice across the biotechnology and pharmaceutical industries, similar to companies like Biogen or Gilead Sciences, to align executive incentives with shareholder value.
• The automatic sale of shares to cover tax withholding upon RSU vesting is also a common and standard procedure, often referred to as a "sell-to-cover" transaction, widely adopted by companies to manage tax obligations for equity awards. This is consistent with practices seen at major tech or healthcare firms.

Related Party Transactions

• The reported transactions involve an insider (Interim CFO Lori Firmani) and the company's securities, which are by definition related party transactions in the context of SEC reporting.

Stakeholder Impact

• Shareholders: The sale of 147 shares by an insider, while small and for tax purposes, slightly increases the public float. The continued holding of RSUs by the Interim CFO aligns her interests with long-term shareholder value.
• Employees: The RSU vesting and tax-related sale illustrate the company's equity compensation plan, which can be a positive for employee retention and motivation.

Next Steps

• Future vesting of one-sixth of the remaining Restricted Stock Units every six months, contingent on continued employment.

Key Dates

Keywords

Galecto Inc., GLTO, Lori Firmani, Interim CFO, SEC Form 4, Restricted Stock Units, RSU vesting, Stock sale, Insider transaction, Equity compensation, Tax obligations